Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osterweis Fund (OSTFX)

26.40
Net Asset Value
-0.08%
1 Day
+6.11%
Year-to-Date
Overall Morningstar Rating
Large blend
Style or Category
No Load
Sales Expenses
1.03%
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term total return. The fund invests primarily in common stocks of companies that Osterweis Capital Management, Inc. believes offer superior investment value and opportunity for growth. It may invest in companies of any size - large, medium and small. The Adviser focuses on companies that the adviser believes to be undervalued or otherwise out-of-favor in the market, but that have attractive growth prospects. It may invest up to 30% of its assets in equity securities of foreign issuers and/or depositary receipts that are traded on domestic or foreign exchanges, including emerging markets.

Performance

1 month+4.06% 3 years+3.20%
3 months+8.92% 5 years+9.34%
1 year+19.03% Since inception+10.23%
Data through --

Peer Comparisonvs. Large blend

 OSTFXCategory
Performance 5-yr return+9.34%+13.18%
Expense ratio1.03%1.02%
Risk 5 year sharpe ratio0.911.15
Net assets$410.5M$4.5B
Average market cap$36.9B$105.4B
Average P/E21.320.7
Portfolio turnover20%20%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyOsterweis
Fund manager & tenureJohn Osterweis / 23 Years
Minimal initial investment$5,000.00
Minimum IRA investment$1,500.00

Holdings

U.S. stock78.77%
International stock13.83%
Cash7.40%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 20.69%
Energy 19.88%
Industrial materials 10.60%
Consumer goods 10.57%
Financial service 9.14%
Top 10 Holdings
Portfolio weighting
CHTR Charter Communications Inc5.23%
GOOG Google5.00%
INTC Intel3.39%
AL Air Lease Corp3.36%
BA Boeing3.35%
BERY Berry Plastics Group Inc3.34%
PGR Progressive Corp3.32%
EPD Enterprise Products Partners LP3.21%
BAYRY Bayer3.12%
CCK Crown Holdings Inc3.08%